Microduplication of the ARID1A gene causes intellectual disability with recognizable syndromic features
Purpose: To determine whether duplication of the ARID1A gene is responsible for a new recognizable syndrome. Methods: We describe four patients with a 1p36.11 microduplication involving ARID1A as identified by array–comparative genomic hybridization . We performed comparative transcriptomic analysis...
Gespeichert in:
Veröffentlicht in: | Genetics in medicine 2017-06, Vol.19 (6), p.701-710 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose:
To determine whether duplication of the
ARID1A
gene is responsible for a new recognizable syndrome.
Methods:
We describe four patients with a 1p36.11 microduplication involving
ARID1A
as identified by array–comparative genomic hybridization . We performed comparative transcriptomic analysis of patient-derived fibroblasts using RNA sequencing and evaluated the impact of
ARID1A
duplication on the cell cycle using fluorescence-activated cell sorting. Functional relationships between differentially expressed genes were investigated with ingenuity pathway analysis (IPA).
Results:
Combining the genomic data, we defined a small (122 kb), minimally critical region that overlaps the full
ARID1A
gene. The four patients shared a strikingly similar phenotype that included intellectual disability and microcephaly. Transcriptomic analysis revealed the deregulated expression of several genes previously linked to microcephaly and developmental disorders as well as the involvement of signaling pathways relevant to microcephaly, among which the polo-like kinase (PLK) pathway was especially notable. Cell-cycle analysis of patient-derived fibroblasts showed a significant increase in the proportion of cells in G1 phase at the expense of G2-M cells.
Conclusion:
Our study reports a new microduplication syndrome involving the
ARID1A
gene. This work is the first step in clarifying the pathophysiological mechanism that links changes in the gene dosage of
ARID1A
with intellectual disability and microcephaly.
Genet Med
advance online publication 01 December 2016 |
---|---|
ISSN: | 1098-3600 1530-0366 |
DOI: | 10.1038/gim.2016.180 |